Authors

Erinn H. Goldman, PhD
Latest Article

Research on bladder tissue regeneration progresses

Atlanta-Tissue engineering research has grown by leaps and bounds in the past decade and a half, yielding findings that may someday have a profound impact on the field of pediatric urology. At the 2006 American Academy of Pediatrics Section on Urology annual meeting here, several groups presented cutting-edge data on novel systems for organ generation, including research demonstrating the feasibility of generating a functioning bladder from stem cells.

Michael O. Koch, MD

Michael O. Koch, MD, is professor and chairman of the department of urology, Indiana University School of Medicine, Indianapolis.

Latest Article

HIFU may offer advantages in PCa, but the jury is still out

Over the last 20 years, radical retropubic prostatectomy has evolvedto become the standard of care in men with localized prostate cancer. Becauseof the morbidity of this procedure, however, interest has grown in the developmentof non-surgical modalities. Unfortunately, many of these non-surgical approaches,such as monotherapy with radioactive seed implantation, have resulted indisappointing results or excessive morbidity, as in first-generation cryotherapy.

Dawn Collins, JD

MS COLLINS is an attorney specializing in medical malpractice in Long Beach, California. She welcomes feedback on this column via e-mail. Click on the envelope icon to email.

Latest Article

Wrong testicle removed during surgery

"At trial, the urology expert testified that the defendant urologist failed to offer the patient alternative treatments before proceeding with the drastic option of removing the testicle," writes Dawn Collins, JD.

Patricia M. Fernberg
Latest Article

Low-dose CT stone detection: Safe during pregnancy

Treatment for pregnant women who present with renal or ureteral colic may have become easier for physician and patient alike.

J. Stephen Jones, MD
Latest Article

Survey data show positive signs for urology's future

The most recent Urology Times State of the Specialty survey is notable in confirming some widely accepted urologic practice trends, but challenging the significance of others.

Kevin Tomera, MD
Latest Article

How to administer anesthesia in the urology office

The procedure should be of a durationand complexity that will permit the patient to recover and be discharged.

Dean G. Assimos, MD

Dean G. Assimos, MD, is professor of urology, department of urology, Wake Forest University School of Medicine, Winston-Salem, NC

Latest Article

Evolution of ureteral stents: Work is still needed

Several approaches have been taken to attenuate lower urinary tract symptoms and improve quality of life in the stented patient.

Brian R. Matlaga, MD, PhD

Brian R. Matlaga, MD, MPH, is a resident in the department of urology, Wake Forest University School of Medicine, Winston-Salem, NC.

Latest Article

How to perform metabolic evaluation in stone formers

Patients with nephrolithiasis frequently have metabolic abnormalities that promote calculus formation and, when identified and corrected, may attenuate stone activity.

Alison Palkhivala
Latest Article

Newer PNL methods improve safety, reduce morbidity

Montreal--Novel approaches to percutaneous nephrolithotomy, includinguse of a stent instead of a tube and using smaller tubes and stone "cones,"are helping to optimize this procedure. Researchers agree that improvingsafety and reducing morbidity are the goals of these new techniques.

Judy Capko

Judy Capko is a health care consultant and the author of "Secrets of the Best Run Practices."

Latest Article

Your high-maintenance urology office staffer: Worth the hassle?

Every urology practice faces this situation eventually: a difficult employee who demands disproportionate time and attention from management.

Joel M. Blau, CFP

Mr. Blau is chief executive officer of MEDIQUS Asset Advisors, Inc., in Chicago. He can be reached at 800-883-8555 or blau@medquis.com.

Latest Article

Preserve assets for heirs after second marriage

A relatively simple technique called the spousal lifetime access trust has proven especially advantageous and popular among those who have remarried and want to provide for children from a prior marriage.

Laird Harrison
Latest Article

Sword, fire, ice offer options in small renal masses

Nephron-sparing procedures now have clear advantages over radical nephrectomy for most small renal masses.

Shandra Wilson, MD
Latest Article

Using bisphosphonates to treat PCa-related bone events

Prostate cancer is the most prevalent non-cutaneous cancer diagnosed in men today, still accounting for a significant amount of morbidity and mortality in spite of increased screening efforts and advances in treatment.

E. David Crawford, MD
Latest Article

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.

J. Brantley Thrasher, MD
Latest Article

ABU makes changes to reduce burden during pandemic

"During these times of uncertainty, panic, and social distancing associated with COVID-19, the American Board of Urology is sensitive to the additional stress this pandemic has placed on urology practices and urologists’ ability to meet their certificate requirements," writes J. Brantley Thrasher, MD.

Fred Gebhart
Latest Article

Comet assay may predict assisted reproductive techniques pregnancy success

There is a significant correlation between Comet assay results and the likelihood of pregnancy using ART.

Badrinath R. Konety

Badrinath R. Konety, MD, is the assistant professor, department of urology, University of Iowa, and chief of the urology service, VA Medical Center, Iowa City.

Latest Article

Bladder cancer data must be taken in context

New bladder cancer data are food for thought, but are not conclusive proof that urologists are over-treating early-stage bladder cancer and running up costs.

Brian R. Matlaga, MD, MPH
Latest Article

Study of stone pain stresses personalized treatment

"This work is important to our field, because it represents an effort to personalize treatment approaches to particular patients’ needs," writes Brian R. Matlaga, MD, MPH.

Scott MacDiarmid, MD

Dr. MacDiarmid is Associate Professor, Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC. He serves as an advisor to Ortho-McNeil Pharmaceuticals and Watson Pharmaceuticals.

Latest Article

PTNS for overactive bladder: Patient selection and technique

This article provides a real-world definition of refractory overactive bladder and its prevalence, then examines treatment options, with a focus on percutaneous tibial nerve stimulation as a noninvasive form of neuromodulation “for the masses.”

Mary Beth Nierengarten
Latest Article

Partial nephrectomy shows increased survival benefit

A recently published population-based study reinforces prior evidence from retrospective studies of the increased survival benefit of partial nephrectomy over radical nephrectomy, and suggests a cancer-specific survival benefit for nephron-sparing approaches as well.

Ramakrishna Venkatesh, MD
Latest Article

Recurrent stone disease: Steps for practical management

Between 30% and 60% of calcium oxalate stone patients have hypercalciuria in the absence of raised serum calcium levels.

Khalid Badwan, MD
Latest Article

Recurrent stone disease: Steps for practical management

Between 30% and 60% of calcium oxalate stone patients have hypercalciuria in the absence of raised serum calcium levels.

Michael Cookson, MD
Latest Article

Prostate cancer and CV risk: The heart of the matter

"Perhaps there is another Nobel Prize waiting to be had if we could reduce the cardiovascular effect of ADT and unlock the answer to the controversy surrounding the comparative safety and impact on cardiovascular health between GnRH agonists and antagonists," writes Michael S. Cookson, MD, MMHC.

Nicholas Mulcahy
Latest Article

Delaying surgery safe in von Hippel-Lindau patients

San Francisco--Even though patients with von Hippel-Lindau disease are at risk for renal tumors and eventual metastatic RCC, parenchymal-sparing surgery can be delayed until the largest tumor reaches 3 cm with minimal concern that the patient will develop metastatic renal cell carcinoma, according to updated data from an ongoing National Institutes of Health study.

Jill C. Buckley, MD
Latest Article

The male sling for SUI: Indications and techniques

The male sling achieves continence by unilateral ventral urethral compression that does not require patient activation, allowing volitional and spontaneous voiding.

Jack W. McAninch, MD
Latest Article

The male sling for SUI: Indications and techniques

The male sling achieves continence by unilateral ventral urethral compression that does not require patient activation, allowing volitional and spontaneous voiding.

J. Brantley Thrasher, MD

Dr. Thrasher, a Urology Times editorial consultant, is professor and chair of urology at the University of Kansas Medical Center, Kansas City.

Latest Article

The BCG shortage: What's being done—and what you can do

In this interview, Seth P. Lerner, MD, discusses current recommendations for managing patients during the BCG shortage, what the FDA is doing to resolve the problem, and a SWOG trial testing a new strain of BCG.

Mark Painter

Mark Painter is CEO of PRS Urology SC in Denver.

Latest Article

How to bill for catheter placement in the hospital setting

In this "Coding Q&A" column, Ray Painter, MD, and Mark Painter also answer questions regarding bladder instillations and penile modeling during IPP placement.

Shlomo Raz, MD
Latest Article

Urologists, GYNs demonstrate slings’ safety

"An abstract authored by Löppenberg et al is an interesting analysis of information from a respected prospective database examining variations in the quality of care provided to patients undergoing sling placement by gynecologists and urologists," write Seth A. Cohen, MD, and Shlomo Raz, MD.

Yair Lotan, MD
Latest Article

Yair Lotan, MD, on navigating the next chapter in BCG-unresponsive NMIBC

Explore the evolving landscape of non-muscle invasive bladder cancer treatments, focusing on the promising gene therapy detalimogene voraplasmid and its trial results.
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us